Loading
If a blood test reliably shows whether cancer will come back after surgery, trials could use it instead of waiting years for relapse. Regulators have a process to bless such a test; oncology should use it.
FDA's Biomarker Qualification Program creates a drug-independent, context-of-use qualification for biomarkers. ctDNA clearance after adjuvant therapy correlates strongly with recurrence in colorectal, bladder and lung cancer, and trial-level meta-analysis is becoming possible as ctDNA-guided trials report. A consortium submission to qualify ctDNA clearance as a reasonably likely surrogate for disease-free survival in defined settings would let adjuvant trials read out in one to two years rather than five.
Shares ctDNA-guided adjuvant therapy as the default in stage II-III colon cancer, GALAXY: tumour DNA in blood four weeks after bowel cancer surgery predicts relapse tenfold, CIRCULATE-Japan (GALAXY / VEGA / ALTAIR), DYNAMIC.
Shares ctDNA MRD → adjuvant therapy decision, IMvigor011, Signatera, ctDNA tests roadmap: from a curiosity in plasma to blood tests that decide treatment.
Shares IMvigor011, DYNAMIC, Signatera, Dormant cells and minimal residual disease.
Shares IMvigor011, CIRCULATE-Japan (GALAXY / VEGA / ALTAIR), DYNAMIC, Diagnostics roadmap: stains → gene panels → blood tests that decide treatment.
Shares ctDNA MRD → adjuvant therapy decision, ctDNA-guided adjuvant therapy as the default in stage II-III colon cancer, GALAXY: tumour DNA in blood four weeks after bowel cancer surgery predicts relapse tenfold, DYNAMIC.
Shares ctDNA MRD → adjuvant therapy decision, CIRCULATE-Japan (GALAXY / VEGA / ALTAIR), DYNAMIC, Signatera.
Shares GALAXY: tumour DNA in blood four weeks after bowel cancer surgery predicts relapse tenfold, CIRCULATE-Japan (GALAXY / VEGA / ALTAIR), DYNAMIC, Signatera.
Shares ctDNA MRD → adjuvant therapy decision, IMvigor011, Signatera, Dormant cells and minimal residual disease.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/